Who is sponsoring NCT01820780?

NCT01820780 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT01820780?

Interventions in NCT01820780: Natriuretic peptides levels to J7 and J14, Consultations specialized to J7 and J14, Phone calls in 6 months and 12 months, Natriuretic peptides levels at 6 months, Consultation with the general doctor or the cardiologist to J30 with blood results.

What condition does NCT01820780 study?

NCT01820780 studies Heart Failure.

Is NCT01820780 still recruiting?

NCT01820780 is currently completed. Last updated 23 September 2021.

Last reviewed 2021-09-23 · How we verify

NCT01820780: ECAD-HF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Care After Discharge of HF Patients

Completed NA Last updated 23 September 2021

What this trial tests

NA trial testing Natriuretic peptides levels to J7 and J14 in Heart Failure in 507 participants. Completed in 11 June 2019.

Timeline

10 June 2013

Primary endpoint
27 March 2019

11 June 2019

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	507
Start date	10 June 2013
Primary completion	27 March 2019
Estimated completion	11 June 2019
Sites	1 location across France

Drugs / interventions tested

Natriuretic peptides levels to J7 and J14
Consultations specialized to J7 and J14
Phone calls in 6 months and 12 months
Natriuretic peptides levels at 6 months
Consultation with the general doctor or the cardiologist to J30 with blood results

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After decompensated heart failure, a number of patients have high risk of early rehospitalization as well as death. Specialized medical management for a short period but very early after discharge could be critical for optimizing care and improving early outcome. This study aims to compare such early intensive medical management with usual care in high-risk patients after discharge.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Disease management interventions for heart failure.
Takeda A, Martin N, Taylor RS, Taylor SJ. · · 2019 · cited 91× · PMID 30620776 · DOI 10.1002/14651858.cd002752.pub4

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01820780 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 23 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01820780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing